Skip to main content

MoneyWorks4Me

Aurobindo Pharma informs about press release

31 Aug 2026 Evaluate
Aurobindo Pharma has informed that it enclosed a copy of the Press Release that is being issued by the Company in connection with launch of generic version of Advair Diskus® in the US by Lannett Company LLC, wholly owned stepdown subsidiary of the Company.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1885.10
Dr. Reddys Labs. 1390.50
Cipla 1414.95
Lupin 2010.00
Zydus Lifesciences 1195.05
View more..